These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12706076)

  • 1. CD81 engineered with endocytotic signals mediates HCV cell entry: implications for receptor usage by HCV in vivo.
    Tan YJ; Lim SP; Ng P; Goh PY; Lim SG; Tan YH; Hong W
    Virology; 2003 Apr; 308(2):250-69. PubMed ID: 12706076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
    Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
    J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
    Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.
    Wünschmann S; Medh JD; Klinzmann D; Schmidt WN; Stapleton JT
    J Virol; 2000 Nov; 74(21):10055-62. PubMed ID: 11024134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
    Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
    J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
    Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
    J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding.
    Rothwangl KB; Manicassamy B; Uprichard SL; Rong L
    Virol J; 2008 Mar; 5():46. PubMed ID: 18355410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.
    Chen Z; Zhu Y; Ren Y; Tong Y; Hua X; Zhu F; Huang L; Liu Y; Luo Y; Lu W; Zhao P; Qi Z
    PLoS One; 2011 Apr; 6(4):e18933. PubMed ID: 21526201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
    Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
    J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
    Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
    J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
    Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT
    J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.
    Triyatni M; Saunier B; Maruvada P; Davis AR; Ulianich L; Heller T; Patel A; Kohn LD; Liang TJ
    J Virol; 2002 Sep; 76(18):9335-44. PubMed ID: 12186916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor.
    Masciopinto F; Campagnoli S; Abrignani S; Uematsu Y; Pileri P
    Virus Res; 2001 Nov; 80(1-2):1-10. PubMed ID: 11597743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse CD81 proteins support hepatitis C virus infection.
    Flint M; von Hahn T; Zhang J; Farquhar M; Jones CT; Balfe P; Rice CM; McKeating JA
    J Virol; 2006 Nov; 80(22):11331-42. PubMed ID: 16943299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.
    Bartosch B; Dubuisson J; Cosset FL
    J Exp Med; 2003 Mar; 197(5):633-42. PubMed ID: 12615904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.
    Patel AH; Wood J; Penin F; Dubuisson J; McKeating JA
    J Gen Virol; 2000 Dec; 81(Pt 12):2873-2883. PubMed ID: 11086118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.
    Zhao X; Tang ZY; Klumpp B; Wolff-Vorbeck G; Barth H; Levy S; von Weizsäcker F; Blum HE; Baumert TF
    J Clin Invest; 2002 Jan; 109(2):221-32. PubMed ID: 11805134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
    McKeating JA; Zhang LQ; Logvinoff C; Flint M; Zhang J; Yu J; Butera D; Ho DD; Dustin LB; Rice CM; Balfe P
    J Virol; 2004 Aug; 78(16):8496-505. PubMed ID: 15280458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus entry: potential receptors and their biological functions.
    Cocquerel L; Voisset C; Dubuisson J
    J Gen Virol; 2006 May; 87(Pt 5):1075-1084. PubMed ID: 16603507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of hepatitis C virus to CD81.
    Pileri P; Uematsu Y; Campagnoli S; Galli G; Falugi F; Petracca R; Weiner AJ; Houghton M; Rosa D; Grandi G; Abrignani S
    Science; 1998 Oct; 282(5390):938-41. PubMed ID: 9794763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.